Gallacher Capital Management LLC Alkermes Plc. Transaction History
Gallacher Capital Management LLC
- $202 Billion
- Q4 2024
A detailed history of Gallacher Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gallacher Capital Management LLC holds 7,568 shares of ALKS stock, worth $241,873. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,568Holding current value
$241,873% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
365Shares Held
179MCall Options Held
145KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$930 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$591 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$415 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$405 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$294 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.25B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...